Price T Rowe Associates Inc Kala Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $34,558 - $150,905	-115,195 Reduced 88.07%	15,600 $5,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $26,572 - $80,154	-43,562 Reduced 24.98%	130,795 $180,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $46,516 - $109,874	40,100 Added 29.87%	174,357 $211,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $203,050 - $420,825	77,500 Added 136.55%	134,257 $352,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $68,153 - $109,772	13,469 Added 31.11%	56,757 $301,000
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $50,724 - $77,875	8,129 Added 23.12%	43,288 $292,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $220,798 - $309,047	35,159 New	35,159 $238,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.81M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.